Literature DB >> 1417789

Identification of a dopamine-binding protein on the membrane of the human platelet.

B Dean1, A J McAdam, S Sundram, G Pavey, L C Harrison, D L Copolov.   

Abstract

The binding of [3H]dopamine to platelet membranes has been examined in an attempt to identify the putative dopamine-uptake mechanism of the platelet. [3H]Dopamine has been shown to bind to a 42,000 Da glycoprotein in platelet membrane with high affinity (Kd = 22.6 nM) and binding of [3H]dopamine was competed for by dopamine, molecules with catechol moieties, 5-hydroxytryptamine, GSH and ascorbic acid. Differences in pharmacological profile and molecular mass suggest that [3H]dopamine does not bind to a known receptor, a neuronal-type dopamine transporter or the platelet 5-hydroxytryptamine-uptake site. It is proposed that this novel binding site for dopamine, which has been purified 1000-fold from particulate platelet membrane, is likely to be a component of the dopamine-uptake mechanism of the human platelet.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417789      PMCID: PMC1133121          DOI: 10.1042/bj2870045

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Cooperativity in ligand binding: a new graphic analysis.

Authors:  P De Meyts; J Roth
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

Review 2.  Dopamine uptake: a review of progress in the last decade.

Authors:  A S Horn
Journal:  Prog Neurobiol       Date:  1990       Impact factor: 11.685

3.  Cloning of human dopamine receptor.

Authors: 
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

4.  Dopamine uptake by the human platelet: effects of dopamine receptor agonists.

Authors:  B Dean; D L Copolov
Journal:  Eur J Pharmacol       Date:  1989-12-07       Impact factor: 4.432

5.  Ascorbic acid, redox cycling, lipid peroxidation, and the binding of dopamine receptor antagonists.

Authors:  R E Heikkila; L Manzino
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

6.  The accumulation and metabolism of dopamine by the human platelet.

Authors:  H M Solomon; N M Spirt; W B Abrams
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

7.  Saturable (3H)cocaine binding in central nervous system of mouse.

Authors:  M E Reith; H Sershen; A Lajtha
Journal:  Life Sci       Date:  1980-09-22       Impact factor: 5.037

8.  A comparative uptake study of serotonin, dopamine, and norepinephrine by platelets of acute schizophrenic patients.

Authors:  A Rotman; H Munitz; I Modai; S Tjano; H Wijsenbeek
Journal:  Psychiatry Res       Date:  1980-12       Impact factor: 3.222

9.  Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.

Authors:  S Shimada; S Kitayama; C L Lin; A Patel; E Nanthakumar; P Gregor; M Kuhar; G Uhl
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

10.  An assay to measure the simultaneous uptake of [3H]dopamine and [14C]serotonin by the human platelet reveals an imipramine-insensitive [3H]dopamine uptake mechanism.

Authors:  B Dean; D L Copolov
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

View more
  4 in total

1.  Regulation of platelet function by catecholamines in the cerebral vasculature of the rabbit.

Authors:  M Emerson; W Paul; C P Page
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Binding of 3H-WIN-35,428 and 125I-RTI-121 to human platelet membranes.

Authors:  Donatella Marazziti; Stefano Baroni; Laura Fabbrini; Paola Italiani; Mario Catena; Bernardo Dell'Osso; Laura Betti; Gino Giannaccini; Antonio Lucacchini; Giovanni B Cassano
Journal:  Neurochem Res       Date:  2006-05-03       Impact factor: 3.996

Review 3.  Role of neurotransmitters in the regulation of cutaneous wound healing.

Authors:  Divya Gupta; Dhirender Kaushik; Vandana Mohan
Journal:  Exp Brain Res       Date:  2022-04-30       Impact factor: 1.972

Review 4.  Immunomodulatory Effects Mediated by Dopamine.

Authors:  Rodrigo Arreola; Samantha Alvarez-Herrera; Gilberto Pérez-Sánchez; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Enrique Octavio Flores-Gutierrez; María Eugenia Garcés-Alvarez; Dora Luz de la Cruz-Aguilera; Emilio Medina-Rivero; Gabriela Hurtado-Alvarado; Saray Quintero-Fabián; Lenin Pavón
Journal:  J Immunol Res       Date:  2016-10-04       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.